Carrera Capital Advisors Makes New $1.30 Million Investment in HealthEquity, Inc. (NASDAQ:HQY)

Carrera Capital Advisors acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 15,868 shares of the company's stock, valued at approximately $1,299,000.

A number of other large investors also recently bought and sold shares of HQY. International Assets Investment Management LLC purchased a new position in shares of HealthEquity in the 2nd quarter valued at about $35,000. Paladin Wealth LLC purchased a new position in shares of HealthEquity in the 3rd quarter valued at about $39,000. GAMMA Investing LLC increased its holdings in shares of HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company's stock valued at $51,000 after purchasing an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of HealthEquity in the 2nd quarter valued at about $73,000. Finally, 1620 Investment Advisors Inc. purchased a new position in shares of HealthEquity in the 3rd quarter valued at about $112,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Buying and Selling

In related news, Director Frank Corvino sold 1,039 shares of the firm's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now directly owns 3,784 shares of the company's stock, valued at approximately $363,642.40. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Frank Corvino sold 1,039 shares of the firm's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares in the company, valued at $363,642.40. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,536 shares of company stock valued at $884,517. Insiders own 2.20% of the company's stock.

HealthEquity Trading Up 0.4 %

Shares of HQY traded up $0.43 during mid-day trading on Tuesday, hitting $100.70. The company had a trading volume of 88,241 shares, compared to its average volume of 613,034. The business's 50-day simple moving average is $83.57 and its 200-day simple moving average is $80.60. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $101.17. The stock has a market cap of $8.79 billion, a PE ratio of 83.56, a P/E/G ratio of 1.55 and a beta of 0.52.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The business had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. Sell-side analysts forecast that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HQY has been the topic of a number of research reports. Bank of America lowered their price objective on shares of HealthEquity from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Wednesday, September 4th. JMP Securities reissued a "market outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Barrington Research reissued an "outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. Royal Bank of Canada reissued an "outperform" rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $102.00 to $103.00 and gave the stock a "buy" rating in a research note on Wednesday, September 4th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, HealthEquity currently has a consensus rating of "Buy" and an average target price of $103.83.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.